OA12133A - Sustained-releasing anthelmintic compositions comprising praziquantel. - Google Patents

Sustained-releasing anthelmintic compositions comprising praziquantel. Download PDF

Info

Publication number
OA12133A
OA12133A OA1200200202A OA1200200202A OA12133A OA 12133 A OA12133 A OA 12133A OA 1200200202 A OA1200200202 A OA 1200200202A OA 1200200202 A OA1200200202 A OA 1200200202A OA 12133 A OA12133 A OA 12133A
Authority
OA
OAPI
Prior art keywords
composition
praziquantel
préparation
sustained
releasing
Prior art date
Application number
OA1200200202A
Other languages
English (en)
Inventor
Sung-Tae Hong
Jeong-Cheol Joo
Weon-Gyu Kho
Krseung-Jin Lee
Original Assignee
Shin Poong Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Poong Pharmaceutical Co filed Critical Shin Poong Pharmaceutical Co
Publication of OA12133A publication Critical patent/OA12133A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA1200200202A 1999-12-30 2000-12-26 Sustained-releasing anthelmintic compositions comprising praziquantel. OA12133A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990065917A KR100360828B1 (ko) 1999-12-30 1999-12-30 프라지콴텔을 포함하는 서방성 구충제 조성물

Publications (1)

Publication Number Publication Date
OA12133A true OA12133A (en) 2006-05-05

Family

ID=19633073

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200202A OA12133A (en) 1999-12-30 2000-12-26 Sustained-releasing anthelmintic compositions comprising praziquantel.

Country Status (7)

Country Link
JP (1) JP2003519172A (pt)
KR (1) KR100360828B1 (pt)
CN (1) CN1414847A (pt)
AU (1) AU2234501A (pt)
BR (1) BR0016866A (pt)
OA (1) OA12133A (pt)
WO (1) WO2001049269A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
WO2009023013A1 (en) * 2007-08-13 2009-02-19 Alpharma, Inc. Praziquantel and cmetidine compositions and methods
CN107073298A (zh) * 2014-02-14 2017-08-18 帝斯曼知识产权资产管理有限公司 用于预防和/或治疗血吸虫病的组合物和方法
US20170157102A1 (en) * 2014-07-16 2017-06-08 Consiglio Nazionale Delle Ricerche Use of perhexiline
CN104814931B (zh) * 2015-04-14 2017-12-26 华南农业大学 一种喹乙醇缓释颗粒及其制备方法和应用
JP7268340B2 (ja) * 2018-12-06 2023-05-08 コニカミノルタ株式会社 ３ｄプリンター成形用樹脂組成物及びそれを用いた成形体とその製造方法
CN114306268A (zh) * 2021-12-28 2022-04-12 恒诚制药集团淮南有限公司 一种吡喹酮薄膜包衣制剂及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
KR100360828B1 (ko) 2002-11-13
CN1414847A (zh) 2003-04-30
BR0016866A (pt) 2002-09-24
WO2001049269A1 (en) 2001-07-12
JP2003519172A (ja) 2003-06-17
KR20010057545A (ko) 2001-07-04
AU2234501A (en) 2001-07-16

Similar Documents

Publication Publication Date Title
US6555133B2 (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
PT85353B (pt) Processo de preparacao de composicoes farmaceuticas de libertacao controlada e de matriz a base de alcool alifatico e resina acrilica
KR19980702370A (ko) 염기성 물질로 안정화된 약제학적 조성물
HRP20010332A2 (en) Pharmaceutical moxifloxacin preparation
EP0724441A1 (en) Picosulphate dosage form
US3459850A (en) Sustained-release tablets,a process and a composition for their preparation
SK74494A3 (en) Pharmaceutical composition and process for the preparation thereof
OA12133A (en) Sustained-releasing anthelmintic compositions comprising praziquantel.
JPH01100118A (ja) ホスホジエステラーゼ阻害剤及びトロンボキサンａ↓２拮抗剤を含む新規な医薬組成物、その使用及びその製造法
RU2261098C2 (ru) Перорально распадающаяся композиция, содержащая миртазапин
US5047235A (en) Pharmaceutical preparations having an antihypertensive and cardioprotective effect
CA2602000A1 (en) Solid oral dosage form of valopi citabine (val-mcyd) and method of preparing it
CA1219216A (en) Ph independent controlled release tablets
CA2671001A1 (en) Pharmaceutical composition of memantine
EA002428B1 (ru) Стабильные композиции, содержащие левозимендан и альгиновую кислоту
WO2019241495A1 (en) Pharmaceutical composition and method for acute on chronic liver failure
US4363809A (en) Organic compounds
JP3935539B2 (ja) フマル酸ケトチフェン含有医薬組成物
JPS59144717A (ja) 鎮痛剤
CA2558219C (en) Poorly water-soluble drug-containing solid formulation
US5182285A (en) Cell-protective composition for preventing or treating of peptic ulcer
JPH01135718A (ja) 放射線障害治療剤
CN114762687A (zh) 一种钾离子竞争性酸阻滞剂的预混物及其制备
CN101062047B (zh) 一种含有异甘草酸和苦参素的组合物及其用途
JPS61236725A (ja) 脳浮腫抑制剤